Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 2, 2011, Pages 166-171

  Singh, P ^a   Arrevad, P S ^a   Peterson, G M ^b   Bereznicki, L R ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

anticoagulants; elderly; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PHENINDIONE; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DRUG USE; ELDERLY CARE; FEMALE; HEART ATRIUM FIBRILLATION; HOME FOR THE AGED; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; DRUG UTILIZATION REVIEW; FEMALE; FIBRINOLYTIC AGENTS; HOMES FOR THE AGED; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; NURSING HOMES; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TASMANIA;

EID: 79952262872     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01167.x     Document Type: Article

References (25)

1. Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC, (2006) The risks of warfarin use in the elderly. Expert Opinion on Drug Safety, 5, 417-431.
2. Go AS, Singer DE, (2008) Stroke prevention in atrial fibrillation: another step sideways. Lancet, 371, 278-280. (Pubitemid 351754771)
3. Hart RG, Pearce LA, Aguilar MI, (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine, 146, 857-867. (Pubitemid 351650486)
4. Burgess CL, Holman CD, Satti AG, (2005) Adverse drug reactions in older Australians, 1981-2002. The Medical Journal of Australia, 182, 267-270. (Pubitemid 40425878)
5. Peterson GM, Boom K, Jackson SL, Vial JH, (2002) Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Internal Medicine Journal, 32, 15-23. (Pubitemid 36124632)
6. Beyth RJ, (2008) Are nursing-home residents at high risk of warfarin-related complications? Nature Clinical Practice Cardiovascular Medicine, 5, 126-127.
7. Gurwitz JH, Field TS, Radford MJ, et al. (2007) The safety of warfarin therapy in the nursing home setting. The American Journal of Medicine, 120, 539-544. (Pubitemid 46779036)
8. Lackner TE, Battis GN, (1995) Use of warfarin for nonvalvular atrial fibrillation in nursing home patients. Archives of Family Medicine, 4, 1017-1026.
9. Lau E, Bungard TJ, Tsuyuki RT, (2004) Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation. Journal of the American Geriatrics Society, 52, 428-433. (Pubitemid 38339526)
10. McCormick D, Gurwitz JH, Goldberg RJ, et al. (2001) Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Archives of Internal Medicine, 161, 2458-2463. (Pubitemid 33043119)
11. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT, (2000) Why do patients with atrial fibrillation not receive warfarin? Archives of Internal Medicine, 160, 41-46. (Pubitemid 30040971)
12. Rossi S, (2009) Australian medicines handbook. Adelaide: Australian Medicines Handbook Pty Ltd.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ, (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Journal of the American Medical Association, 285, 2864-2870. (Pubitemid 32537350)
14. Anonymous (2009) Using antithrombotics wisely in stroke prevention. NPS News, 62, 1-4.
15. Quilliam BJ, Lapane KL, (2001) Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke, 32, 1385-1393.
16. Lawson F, McAlister F, Ackman M, Ikuta R, Montague T, (1996) The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital. Journal of the American Geriatrics Society, 44, 708-711. (Pubitemid 26174391)
17. Jackson SL, Peterson GM, Vial JH, Daud R, Ang SY, (2001) Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice. Internal Medicine Journal, 31, 329-336. (Pubitemid 34225186)
18. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE, (1999) Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Annals of Internal Medicine, 131, 927-934. (Pubitemid 30005032)
19. Man-Son-Hing M, Laupacis A, (2003) Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Archives of Internal Medicine, 163, 1580-1586. (Pubitemid 36835103)
20. Fang MC, (2009) Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. Journal of Interventional Cardiac Electrophysiology, 25, 19-23.
21. Dharmarajan TS, Varma S, Akkaladevi S, Lebelt AS, Norkus EP, (2006) To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation Journal of the American Medical Directors Association, 7, 23-28. (Pubitemid 43224338)
22. Monette J, Gurwitz JH, Rochon PA, Avorn J, (1997) Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. Journal of the American Geriatrics Society, 45, 1060-1065. (Pubitemid 27377551)
23. Mant J, Hobbs FD, Fletcher K, et al. (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet, 370, 493-503. (Pubitemid 47212371)
24. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E, (2004) The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 204S-233S. (Pubitemid 39297955)
25. Burgess C, Ingham T, Woodbridge M, Weatherall M, Nowitz M, (2007) The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Journal of Therapeutics and Clinical Risk Management, 3, 491-498. (Pubitemid 47214990)